These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34972614)

  • 1. Corrigendum to "Polyglutamic acid-based nanocomposites as efficient non-viral gene carriers in vitro and in vivo" [Eur. J. Pharm. Biopharm. 79(3) (2011) 473-484].
    Tripathi SK; Goyal R; Ravi Ram K; Shukla Y; Chowdhuri DK; Gupta KC
    Eur J Pharm Biopharm; 2022 Jan; 170():208-209. PubMed ID: 34972614
    [No Abstract]   [Full Text] [Related]  

  • 2. Corrigendum to "Polyglutamic acid-based nanocomposites as efficient non-viral gene carriers in vitro and in vivo" [Euro. J. Pharm. Biopharm. 79 (2011) 473-484].
    Kumar Tripathi S; Goyal R; Ansari KM; Ravi Ram K; Shukla Y; Chowdhuri DK; Gupta KC
    Eur J Pharm Biopharm; 2018 Dec; 133():161. PubMed ID: 30458953
    [No Abstract]   [Full Text] [Related]  

  • 3. Corrigendum to "Polyethylenimine nanoparticles as an efficient in vitro siRNA delivery system" [Eur. J. Pharm. Biopharm. 73 (2009) 43-49].
    Nimesh S; Chandra R
    Eur J Pharm Biopharm; 2019 Sep; 142():541. PubMed ID: 31470968
    [No Abstract]   [Full Text] [Related]  

  • 4. Corrigendum to "Guanidinium-grafted polyethylenimine: An efficient transfecting agent for mammalian cells" [Eur. J. Pharm. Biopharm. 68 (2008) 647-655].
    Nimesh S; Chandra R
    Eur J Pharm Biopharm; 2019 Sep; 142():542. PubMed ID: 31470969
    [No Abstract]   [Full Text] [Related]  

  • 5. Corrigendum to "Mimicking brain tissue binding in an in vitro model of the blood-brain barrier illustrates differences between in vitro and in vivo methods for assessing the rate of brain penetration" [Eur. J. Pharm. Biopharm. 127 (2018) 453-461].
    Heymans M; Sevin E; Gosselet F; Lundquist S; Culot M
    Eur J Pharm Biopharm; 2018 Dec; 133():200-202. PubMed ID: 30458954
    [No Abstract]   [Full Text] [Related]  

  • 6. Corrigendum to "Pharmacokinetics and in vivo delivery of curcumin by copolymeric mPEG-PCL micelles" [Eur. J. Pharm. Biopharm. 116 (2017) 17-30].
    Manjili HK; Ghasemi P; Malvandi H; Mousavi MS; Attari E; Danafar H
    Eur J Pharm Biopharm; 2019 Sep; 142():280. PubMed ID: 31470966
    [No Abstract]   [Full Text] [Related]  

  • 7. Corrigendum to "An insight of in vitro transport of PEGylated non-ionic surfactant vesicles (NSVs) across the intestinal polarized enterocyte monolayers" [Eur. J. Pharm. Biopharm. 127 (2018) 432-442].
    Primavera R; Palumbo P; Celia C; Cilurzo F; Cinque B; Carata E; Carafa M; Paolino D; Cifone MG; Di Marzio L
    Eur J Pharm Biopharm; 2018 Jul; 128():259. PubMed ID: 29738716
    [No Abstract]   [Full Text] [Related]  

  • 8. Corrigendum to "Andrographolide-loaded nanoparticles for brain delivery: Formulation, characterisation and in vitro permeability using hCMEC/D3 cell line" [Eur. J. Pharm. Biopharm. 119 (2017) 253-263].
    Guccione C; Oufir M; Piazzini V; Eigenmann DE; Jähne EA; Zabela V; Faleschini MT; Bergonzi MC; Smiesko M; Hamburger M; Bilia AR
    Eur J Pharm Biopharm; 2017 Nov; 120():146. PubMed ID: 28941379
    [No Abstract]   [Full Text] [Related]  

  • 9. Corrigendum to "Oral Helicobacter pylori vaccine-encapsulated acid-resistant HP55/PLGA nanoparticles promote immune protection" [Eur. J. Pharm. Biopharm. 111 (2017) 33-43].
    Tan Z; Liu W; Liu H; Li C; Zhang Y; Meng X; Tang T; Xi T; Xing Y
    Eur J Pharm Biopharm; 2019 Dec; 145():96-97. PubMed ID: 31735275
    [No Abstract]   [Full Text] [Related]  

  • 10. Corrigendum to "Functional electrospun fibers for the treatment of human skin wounds" [Eur. J. Pharm. Biopharm. 119 (2017) 283-299].
    Wang J; Windbergs M
    Eur J Pharm Biopharm; 2018 Nov; 132():93. PubMed ID: 30314750
    [No Abstract]   [Full Text] [Related]  

  • 11. Corrigendum to "Anticancer activity of galactoxyloglucan polysaccharide-conjugated doxorubicin nanoparticles: Mechanistic insights and interactome analysis" [Eur. J. Pharm. Biopharm. 93 (2015) 183-195].
    Joseph MM; Aravind SR; George SK; Pillai RK; Mini S; Sreelekha TT
    Eur J Pharm Biopharm; 2021 Apr; 161():1-3. PubMed ID: 33722352
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to "Chitosan-coated liposome dry-powder formulations loaded with ghrelin for nose-to-brain delivery" [Eur. J. Pharm. Biopharm. 129 (2018) 257-266].
    Salade L; Wauthoz N; Vermeersch M; Amighi K; Goole J
    Eur J Pharm Biopharm; 2018 Oct; 131():151. PubMed ID: 30201099
    [No Abstract]   [Full Text] [Related]  

  • 13. Corrigendum to "The chemotherapeutic potential of doxorubicin-loaded PEG-b-PLGA nanopolymersomes in mouse breast cancer model." [Eur. J. Pharm. Biopharm. 94 (2015) 521-531].
    Alibolandi M; Sadeghi F; Abnous K; Atyabi F; Ramezani M; Hadizadeh F
    Eur J Pharm Biopharm; 2019 Sep; 142():540. PubMed ID: 31470967
    [No Abstract]   [Full Text] [Related]  

  • 14. Corrigendum to "Elucidating the weak protein-protein interaction mechanisms behind the liquid-liquid phase separation of a mAb solution by different types of additives" [Eur. J. Pharm. Biopharm. 120 (2017) 1-8].
    Wu G; Wang S; Tian Z; Zhang N; Sheng H; Dai W; Qian F
    Eur J Pharm Biopharm; 2018 Apr; 125():182. PubMed ID: 29428216
    [No Abstract]   [Full Text] [Related]  

  • 15. Corrigendum to "Acid-labile pHPMA modification of four-arm oligoaminoamide pDNA polyplexes balances shielding and gene transfer activity in vitro and in vivo" [Euro. J. Pharm. Biopharm. 105 (2016) 85-96].
    Beckert L; Kostka L; Kessel E; Krhac Levacic A; Kostkova H; Etrych T; Lächelt U; Wagner E
    Eur J Pharm Biopharm; 2017 Apr; 113():240. PubMed ID: 28130965
    [No Abstract]   [Full Text] [Related]  

  • 16. Polyglutamic acid-based nanocomposites as efficient non-viral gene carriers in vitro and in vivo.
    Tripathi SK; Goyal R; Ansari KM; Ravi Ram K; Shukla Y; Chowdhuri DK; Gupta KC
    Eur J Pharm Biopharm; 2011 Nov; 79(3):473-84. PubMed ID: 21820510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erratum to "Ultrasound-mediated nanoparticle delivery across ex vivo bovine retina after intravitreal injection" [Eur. J. Pharm. Biopharm. 119 (2017) 125-136].
    Huang D; Chen YS; Thakur SS; Rupenthal ID
    Eur J Pharm Biopharm; 2018 Feb; 123():117. PubMed ID: 29222046
    [No Abstract]   [Full Text] [Related]  

  • 18. Retraction notice to "Cocrystals of curcumin-isonicotinamide and curcumin-gallic acid: Does the weak forces in cocrystals effect on binding profiles with BSA and cell cytotoxicity?" [Eur. J. Pharm. Biopharm. 140 (2019) 78-90].
    Pang W; Wu Y; Xue N; Li Y; Du S; He B; Yang C; Wang J; Zeng Y
    Eur J Pharm Biopharm; 2019 Sep; 142():563. PubMed ID: 31377112
    [No Abstract]   [Full Text] [Related]  

  • 19. Erratum to "Topical iontophoretic delivery of ionizable, biolabile aciclovir prodrugs: A rational approach to improve cutaneous bioavailability" [Eur. J. Pharm. Biopharm. 99 (2016) 103-113].
    Chen Y; Alberti I; Kalia YN
    Eur J Pharm Biopharm; 2016 May; 102():19. PubMed ID: 27038092
    [No Abstract]   [Full Text] [Related]  

  • 20. Comment on "Gelation of microemulsions and release behaviour of sodium salicylate from gelled microemulsions" [Eur. J. Pharm. Biopharm. 71 (2009) 297].
    Stubenrauch C; Sottmann T; Strey R; Lynch I
    Eur J Pharm Biopharm; 2009 Aug; 72(3):632; author reply 633. PubMed ID: 19454318
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.